Should the standard dimethyl sulfoxide concentration be reduced? Results of a <scp>E</scp>uropean <scp>G</scp>roup for <scp>B</scp>lood and <scp>M</scp>arrow <scp>T</scp>ransplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth C. de Wreede, Marijke Scholten et al.|Transfusion|2014Cited by 94
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUK<i>one</i> randomized dose selection trialSteve Schey, James Cavet, Guillermo Ortí et al.|British Journal of Haematology|2015Cited by 20
Re‐transplantation after bortezomib‐based therapyCurly Morris, Jamie Cavenagh, Gordon Cook et al.|British Journal of Haematology|2011Cited by 8
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma TrialRakesh Popat, Nicholas Counsell, Ruth de Tute et al.|British Journal of Haematology|2021Cited by 5
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myelomaFaith E. Davies, Curly Morris, Jenny Bird et al.|International Journal of Laboratory Hematology|2008Cited by 1